| A4821P | BMP2 Antibody | WB, IF, IHC, ELISA | Human | Rabbit | |
| A4841P | BMP4 Antibody | WB, IHC, ELISA | Human, Mouse, Rabbit, Zebrafish | Rabbit | |
| A4847P | MAPT Antibody | WB, IHC, ELISA | Human, Mouse | Rabbit | |
| A4862P | SRC Antibody | WB, IF, IHC, ELISA | Human, Mouse, Rabbit | Rabbit | |
| A4871P | BMP7 Antibody | WB, IF, IHC | Human, Mouse, Zebrafish | Rabbit | |
| A4877P | G6PD Antibody | IF, IHC, ELISA | Human | Rabbit | |
| A4884P | BDNF Antibody | WB, IHC, ELISA | Human, Mouse | Rabbit | |
| A4897P | GFAP Antibody | WB, IF, IHC | Human, Mouse, Rabbit | Rabbit | |
| A4984P | RPTOR Antibody | IF, IHC, ELISA | Human | Rabbit | |
| A50986ME | CD19 Monoclonal Antibody, APC | FCM | Mouse | Rat | |
| A50990ME | I-A/I-E Monoclonal Antibody, APC | FCM | Mouse | Rat | |
| A50995ME | F4/80 Monoclonal Antibody, APC | FCM | Mouse | Rat | |
| A510001 | Anti-SARS-CoV-2 S-hIgG1 Neutralizing Antibody | Neutralization | | Human |  |
| A510002 | Anti-SARS-CoV-2 S-IgM Neutralizing Antibody (ng/ml) | Neutralization | | Human | |
| A510003 | Anti-SARS-CoV-2 S-IgA Neutralizing Antibody | Neutralization | | Human | |
| A510004 | anti-PD-1 (Nivolumab) | Functional Assay | Human | CHO cells | |
| A510005 | anti-PD-1 (Pembrolizumab) | Functional Assay | Human | CHO cells | |
| A510006 | anti-PD-L1 (Avelumab) | Functional Assay | Human | CHO cells | |
| A510007 | anti-IL-17A (Secukinumab) | Functional Assay | Human | CHO cells | |
| A510008 | anti-TNF-alpha (Adalimumab) | Functional Assay | Human | CHO cells | |
| A510009 | anti-HER2 (Ado-trastuzumab emtansine) | Functional Assay | Human | CHO cells | |
| A510010 | anti-CD52 (Alemtuzumab) | Functional Assay | Human | CHO cells | |
| A510011 | anti-PCSK9 (Alirocumab) | Functional Assay | Human | CHO cells | |
| A510012 | anti-PD-L1 (Atezolizumab) | Functional Assay | Human | CHO cells | |
| A510013 | anti-VEGF (Bevacizumab) | Functional Assay | Human | CHO cells | |
| A510014 | anti-EGFR (Cetuximab) | Functional Assay | Human | CHO cells | |
| A510015 | anti-RANKL (Denosumab) | Functional Assay | Human | CHO cells | |
| A510016 | anti-CD38 (Daratumumab) | Functional Assay | Human | CHO cells | |
| A510017 | anti-Complement C5 (Eculizumab) | Functional Assay | Human | CHO cells | |
| A510018 | anti-PCSK9 (Evolocumab) | Functional Assay | Human | CHO cells | |
.png)